Difficulty: Medium
Average Score: 66%
Practice
All of the following drugs are indirect acting anticoagulants EXCEPT:
Correct answer
C
Rationale
In the context of pharmacology across the lifespan, understanding anticoagulants is crucial due to their widespread use in various age groups for conditions like atrial fibrillation, deep vein thrombosis, and pulmonary embolism.
Dalteparin, the correct answer (C), is a low molecular weight heparin that directly inhibits factor Xa, making it a direct acting anticoagulant. This distinguishes it from the other options which are indirect acting anticoagulants.
Dicumarol (A), Warfarin (B), and Phenindione (D) are all indirect acting anticoagulants that function by interfering with the hepatic synthesis of vitamin K-dependent clotting factors. They work by inhibiting the enzyme vitamin K epoxide reductase.
Educationally, recognizing the distinction between direct and indirect acting anticoagulants is vital for safe and effective medication administration. Understanding the mechanisms of action of these drugs helps healthcare professionals make informed decisions about their use, dosing, monitoring, and potential interactions, especially in the context of managing thrombotic disorders across different age groups.
Dalteparin, the correct answer (C), is a low molecular weight heparin that directly inhibits factor Xa, making it a direct acting anticoagulant. This distinguishes it from the other options which are indirect acting anticoagulants.
Dicumarol (A), Warfarin (B), and Phenindione (D) are all indirect acting anticoagulants that function by interfering with the hepatic synthesis of vitamin K-dependent clotting factors. They work by inhibiting the enzyme vitamin K epoxide reductase.
Educationally, recognizing the distinction between direct and indirect acting anticoagulants is vital for safe and effective medication administration. Understanding the mechanisms of action of these drugs helps healthcare professionals make informed decisions about their use, dosing, monitoring, and potential interactions, especially in the context of managing thrombotic disorders across different age groups.